Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial

File Type:

PDF

Item Type:

Journal Article

Date:

2017

Author:

O'BYRNE, KEN

Access:

openAccess

Citation:

Paz-Ares, L. and Tan, E.-H. and O'Byrne, K. and Zhang, L. and Hirsh, V. and Boyer, M. and Yang, J.C.-H. and Mok, T. and Lee, K.H. and Lu, S. and Shi, Y. and Lee, D.H. and Laskin, J. and Kim, D.-W. and Laurie, S.A. and K??lbeck, K. and Fan, J. and Dodd, N. and M??rten, A. and Park, K., Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: Overall survival data from the phase IIb LUX-Lung 7 trial, Annals of Oncology, 28, 2, 2017, 270-277

Download Item:

  (mdw611.pdf)  400.3Kb

URI:

http://hdl.handle.net/2262/82626

Author's Homepage:

http://people.tcd.ie/obyrneke

Author: O'BYRNE, KEN

Type of material:

Journal Article

URI:

http://hdl.handle.net/2262/82626

Collections

• Clinical Medicine (Scholarly Publications)
• RSS Feeds

Series/Report no:

Annals of Oncology;
28;
2;

Availability:

Full text available

Keywords:

Cancer

DOI:

http://dx.doi.org/10.1093/annonc/mdw611

Metadata

Show full item record